Biomarkers World Congress, Philadelphia, US, May 21st-23rd, 2012
Sabah Malek will present on the Co-Development of Targeted Therapeutics and Companion Diagnostics in the U.S. and EU at the Drug-Diagnostic Co-Development track of the Biomarkers World Congress 2012 in Philadelphia, PA USA on May 21-23, 2012. Her presentation will focus on the major regulatory issues that concern diagnostic and pharmaceutical partners during co-development of a targeted therapeutic and companion diagnostic, including current development trends, coordination of clinical trials, and the regulatory review of both products in the U.S. and EU.
Contact vccambridge for more details.
